NCT06844045

Brief Summary

The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,460

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Feb 2026Dec 2026

First Submitted

Initial submission to the registry

February 19, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 25, 2025

Completed
12 months until next milestone

Study Start

First participant enrolled

February 24, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

10 months

First QC Date

February 19, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

HIV PreventionHIV TestingHIV Pre-Exposure ProphylaxisGonorrheaChlamydiaSexually Transmitted Infections

Outcome Measures

Primary Outcomes (1)

  • Rates of HIV Test Completion

    Rates of HIV test completion on the day of gonorrhea/chlamydia testing will be compared between those who receive point-of-care vs. lab-based STI testing.

    Day 1 - Measured on date of STI testing

Secondary Outcomes (2)

  • Number of participants who received PrEP counseling

    Day 1 - Same day as STI testing encounter

  • Time to STI treatment

    Time from STI diagnosis to treatment, up to 9 months

Study Arms (2)

Point-of-Care Tested

EXPERIMENTAL

Participants in the intervention arm have received point-of-care testing for sexually transmitted infections.

Behavioral: Gonorrhea/chlamydia Point-of-Care Testing

Lab Tested

NO INTERVENTION

Participants in the control arm have received lab-based testing for sexually transmitted infections.

Interventions

Point-of-care testing for sexually transmitted infections.

Point-of-Care Tested

Eligibility Criteria

Age16 Years - 24 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing

You may not qualify if:

  • \- Patients with known HIV or active PrEP prescriptions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

RECRUITING

MeSH Terms

Conditions

GonorrheaChlamydia InfectionsSexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Neisseriaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSexually Transmitted Diseases, BacterialCommunicable DiseasesGenital DiseasesUrogenital DiseasesChlamydiaceae InfectionsDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sarah Wood, MD, MSHP

    Mount Sinai Adolescent Health Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Naomi Pressman, MS, RD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 19, 2025

First Posted

February 25, 2025

Study Start

February 24, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

All of the individual participant data collected during the trial, after deidentification.

Shared Documents
STUDY PROTOCOL, ICF, ANALYTIC CODE
Time Frame
Specify Other Time Frame After the end of the award period. No end date.
Access Criteria
Researchers who provide a methodologically sound proposal. Any purpose. Data will be findable for the research community through the NIHM Data Archive Collection.

Locations